Onychomycosis. III - Treatment;Les onychomycoses. III - Traitement

Journal de Mycologie Medicale

Volumn 11, Issue 4, 2001, Pages 205-215

  Feuilhade de Chauvin, M ^a   Baran, R ^a   Chabasse, Et D ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

Onychomycosis; Treatment

Indexed keywords

AMINOPHYLLINE; ANTIFUNGAL AGENT; ANTIVITAMIN K; ASTEMIZOLE; CAFFEINE; CIMETIDINE; CYCLOSPORIN; CYTOCHROME P450 3A; CYTOCHROME P450 3A4; DIDANOSINE; ESTROGEN; FLUCONAZOLE; GRISEOFULVIN; HYDROCHLOROTHIAZIDE; ISONIAZID; ITRACONAZOLE; KETOCONAZOLE; METHADONE; ORAL CONTRACEPTIVE AGENT; PENICILLAMINE; PHENOBARBITAL; PHENYTOIN; RIFABUTIN; RIFAMPICIN; TACROLIMUS; TERBINAFINE; THEOPHYLLINE; TRIAZOLAM; UNINDEXED DRUG; ZIDOVUDINE;

ANTIFUNGAL ACTIVITY; CANDIDA; DIARRHEA; DRUG CHOICE; DRUG EFFICACY; DRUG METABOLISM; DRUG SAFETY; HUMAN; LIVER TOXICITY; NAUSEA; ONYCHOMYCOSIS; PERIPHERAL NEUROPATHY; RASH; REVIEW; SKIN EXFOLIATION; STEVENS JOHNSON SYNDROME; TASTE DISORDER; TORSADE DES POINTES;

ARTHRODERMATACEAE; CANDIDA; STAPHYLOCOCCUS PHAGE 3A;

EID: 0035709828     PISSN: 11565233     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (66)

1. Lateral edge nail involvement indicates poor pronosis for treating onychomycosis with the new systemic antifungal
2. Uncommon clinical patterns of Fusarium nail infection: Report of three cases
3. A randomised trial of amorolfine 5% nail laquer combined with oral terbinafine compared with terbinafine alone in the treatment of dermatophytic toenail onychomycoses affecting the matrix region
4. Les onychomycoses II. Approches diagnostiques
5. Les onychomycoses I Epidémiologie-étiologie
6. A 12-week treatment for dermatophyte toe onychomycoses terbinafine 250 mg/day vs itraconazole 200 mg/day - A double-blind comparative trial
7. Itraconazole pulse therapy for onychomycoses and dermatomycoses: An overview
8. Itraconazole therapy is effective for pedal onychomycoses caused by some nondermatophyte molds and in mixed infection with dermatophytes and molds: A multicenter study with 36 patients
9. Once-weekly fluconazole (150,300,450 mg) in the treatment of distal subungual onychomycoses of the fingernail
10. Onychomycoses: Pathogenesis, diagnosis and management
11. How often does oral treatment of toenail onychomycosis produce a disease free nail
12. Double blind, randomized study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycoses
13. Double blind, parallel-group comparison of terbinafine and griseofulvin in the treatment of toenail onychomycoses
14. Pharmacokinetics of terbinafine
15. Infections mycosiques et bactériennes de l'appareil unguéal
16. Onychomycosis caused by infection with Paecylomyces lilacinus
17. Short term treatment of dermatophyte onychomycosis with terbinafine
18. Terbinafine: An update
19. Current management of onychomycosis: An overview
20. Onychomycosis in children. Prevalence and treatment strategies
21. Onychomycosis: Strategies to reduce failure and reccurence
22. Cutaneous adverse effects associated with terbinafine therapy: 10 Case reports and a review of the literature
23. Fluconazole for the treatment of onychomycosis: An update
24. Drug interactions with itraconazole, fluconazole, and terbinafine and their management
25. Ciclopirox nail laquer topical solution 8% in the treatment of toenail onychomycoses
26. Savety of oral terbinafine. Results of a post marketing surveillance study in 25 884 patients
27. Short duration treatment of fingernail dermatophytosis: A randomised, double blind study with terbinafine and griseofulvin
28. A double-blind randomized study to compare the efficacy and savety of terbinafine (Lamisil®) with fluconazole (Diflucan®) in the treatement of onychomycosis
29. The management of superficial candidiasis
30. Treatment of toenail onychomycoses: A randomised, double blind study with terbinafine and griseofulvin
31. Onychomycosis treatment: Relapse and reinfection
32. Overview of the use of terbinafine (Lamisil®) in children
33. Systemic antifungal agents to treat onychomycoses
34. Study of the efficacy and tolerability of oral terbinafine in the treatment of onychomycosis in renal transplant patients
35. Effectiveness of amorolfine 5% nail lacquer in the treatment of long duration Candida onychomycosis with chronic paronychia
36. Once-weekly fluconazole (, 450 mg) for 4, 6, 9 months of treatment for distal subungual onychomycoses of the toenail
37. Amorolfine nail lacquer: A novel formulation
38. Itraconazole penetrates the nail via the nail matrix and the nail bed- an investigation in onychomycoses
39. Oral terbinafine treatment for toenail onychomycosis: Follow up after 5-6 years
40. Use of terbinafine in HIV positive subjects: Pilot studies in onychomycosis an oral candidiasis
41. A multicenter, placebo-controlled, double-blind study of intermittent therapy with itraconazole for the treatment of onychomycoses of the fingernails
42. New mechanisms of action with fungicidal antifungals
43. Pharmacokinetics of three doses of once-weekly fluconazole (150, 300, 450 mg) in distal subungual onychomycoses of the toenail
44. Terbinafine (Lamisil®) in the treatment of onychomycoses
45. Subungueal dermatophytoma complicating dermatophyte onychomycosis
46. Terbinafine: Mode of action and properties of the squalene epoxidase inhibition
47. In vitro activity of terbinafine (Lamisil®): An update
48. Pharmacokinetics of three doses of once-weekly fluconazole (150, 300, 450 mg) in distal subungual onychomycoses of the fingernail
49. Nail incorporation kinetics of terbinafine in onychomycoses patients
50. Onychomycoses: Therapeutic update
51. Once-weekly fluconazole (150, 300, 450 mg) in the treatment of distal subungual onychomycoses of the toenail
52. Aspergillus versicolor as cause of onychomycosis: Report of 12 cases and susceptibility testing to antifungal drugs
53. Relapses of onychomycoses after sussessful treatment with systemic antifungal: A three year follow up
54. Proximal subungueal onychomycosis due to Aspergillus niger: Report of two cases
55. Onychomycoses caused by nondermatophytic molds: Clinical features and response to treatment of 59 cases
56. Treatment of onychomycosis with terbinafine in patients with Down's syndrome
57. Terbinafine in onychomycosis of the toenail: A novel treatment protocol
58. Long term follow up of patients with toenail onychomycoses after treatment with terbinafine
59. The dermatophytes
60. Posttreatment itraconazole levels in the nail. New applications for treatment in onychomycoses